Amgen receives positive CHMP opinion to expand use of Prolia (denosumab) to patients with glucocorticoid-induced osteoporosis
Amgen's myeloma treatment Kyprolis gains NICE approval
Improving the Patient Experience for Amgen - UX Design Innovation Studio | Frontend.com
NEUPOGEN® (Filgrastim), 300mcg/mL, SDV, Non-Returnable, 1mL/Vial, 10vials/ Box | McGuff Medical Products
Improving the Patient Experience for Amgen - UX Design Innovation Studio | Frontend.com
Blincyto Shines for Kids' B-Cell ALL | MedPage Today
Amgen Prolia Injection 60Mg, Packaging Type: Box, Rs 8000/box | ID: 22385734791
FDA nod for Novartis sets up cholesterol drug showdown with Amgen, Regeneron - MedCity News
Epogen <br> Anemia Treatment Agent Epoetin Alfa <br> 20,000 U / mL Subcutaneous or Intravenous Injection <br>Multiple Dose Vial 1 mL , 10/Box <br> Amgen 55513047810
Amgen wins a monopoly on a pricey cholesterol drug - STAT
US approves 1st drug developed to prevent chronic migraines | wthr.com
Amgen fortifies Lumakras with more lung cancer data on the KRAS med
Amgen Denosumab Solution for Injection, Packaging Type: Box, Rs 24500/box | ID: 21074813530
Amgen to refund cholesterol drug if patients suffer heart attack | Financial Times
Improving the Patient Experience for Amgen - UX Design Innovation Studio | Frontend.com
Amgen Inc 55513026710 - McKesson Medical-Surgical
Box for Life Sciences and Biotech, Cloud Storage & File Sharing
Xconomy: Drug Price Watchdog ICER Deems Amgen Migraine Drug “Cost-Effective”
Prolia of 60 mg/ml syringe of 1 ml No. 1, Amgen – KSD-Farm | all.biz
Consumer watchdog petitions FDA for black box warning on Amgen's Prolia | Fierce Pharma
Dr.Aziz B. Abdullah - FDA Approves Amgen's Parsabiv (etelcalcetide) for Secondary Hyperparathyroidism in Adult Patients on Hemodialysis Food and Drug Administration (FDA) has approved Parsabiv (etelcalcetide) for the treatment of secondary ...
Improving the Patient Experience for Amgen - UX Design Innovation Studio | Frontend.com
Round 2 Amgen? US FDA accepts Sandoz's Enbrel biosimilar for review
Rituxan® Biosimilar | RIABNI™ (rituximab-arrx)
